<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04850430</url>
  </required_header>
  <id_info>
    <org_study_id>S-173/2021</org_study_id>
    <nct_id>NCT04850430</nct_id>
  </id_info>
  <brief_title>Gastric Venous Reconstruction After Total Pancreatectomy</brief_title>
  <acronym>GENDER</acronym>
  <official_title>Gastric Venous Reconstruction to Reduce Gastric Venous Congestion After Total Pancreatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total pancreatoduodenectomy (TP) is the standard surgical approach for treatment of extended&#xD;
      pancreas tumors. If the gastric coronary vein has to be sacrificed for oncologic or for&#xD;
      technical reasons in total pancreatectomy with splenectomy, gastric venous congestion (GVC)&#xD;
      may result because all major venous draining routes are terminated. In the sequelae of GVC,&#xD;
      gastric venous infarction ultimately leads to gastric perforation with abdominal sepsis. To&#xD;
      avoid gastric venous infarction, partial or even total gastrectomy is usually performed in&#xD;
      the event of GVC after TP. However, this significantly impacts the patient's quality of life.&#xD;
&#xD;
      Reconstruction of gastric venous outflow represents a technical approach to overcome GVC and&#xD;
      to avoid gastric venous infarction making (partial) gastrectomy unnecessary. The current&#xD;
      study aims to assess the role of gastric venous outflow reconstruction in GVC after TP to&#xD;
      prevent (partial) gastrectomy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients will be assigned to study after intraoperative evaluation of gastric venous drainage after coronary vein resection during TP. During surgery, onsite evaluation by the surgeon, endoscopic examination, indocyanine green, gastric venous drainage flowmetry, and spectral analysis will be performed. After surgery, patients will receive standard post-TP care and treatment. During hospitalization, endoscopic examination with indocyanine green will be performed on the first, third, and seventh postoperative day to evaluate gastric ischemia. Ischemia markers will be evaluated daily after surgery. After discharge, patients will be followed up for 30 days, during which mortality and morbidities will be recorded.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of gastric venous congestion</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Gastric venous congestion after gastric venous reconstruction following total pancreatectomy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of gastric ischemia</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Gastric ischemia after gastric venous reconstruction following total pancreatectomy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postpancreatectomy gastrectomy rate</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Rate of gastrectomy after gastric venous reconstruction following total pancreatectomy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reoperation rate</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Reoperation rate after gastric venous reconstruction following total pancreatectomy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morbidity rate</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Complications rate after gastric venous reconstruction following total pancreatectomy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Mortality rate after gastric venous reconstruction following total pancreatectomy</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pancreas Cancer</condition>
  <condition>Pancreatectomy</condition>
  <arm_group>
    <arm_group_label>Gastric venous congestion following total pancreatectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The gastric venous outflow will be reconstructed after TP. The patients will be assessed concerning gastric venous congestion and gastric ischemia intraoperatively before and after venous outflow reconstruction through onsite evaluation by the surgeon, endoscopic examination, indocyanine green, gastric venous drainage flowmetry, and spectral imaging.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gastric venous reconstruction</intervention_name>
    <description>Patients will be assigned to study after intraoperative evaluation of gastric venous drainage after coronary vein resection during TP, and the gastric venous outflow will be reconstructed after TP.</description>
    <arm_group_label>Gastric venous congestion following total pancreatectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥ 18 years&#xD;
&#xD;
          -  Provide written informed consent&#xD;
&#xD;
          -  Elective total pancreatectomy for malignant or benign pancreatic lesions or chronic&#xD;
             pancreatitis with splenectomy&#xD;
&#xD;
          -  Intraoperative ligation of coronary vein&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Gastric resection due to malignant infiltration&#xD;
&#xD;
          -  Non-reconstructable gastric venous drainage&#xD;
&#xD;
          -  Previous pancreas surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Arianeb Mehrabi, MD</last_name>
    <phone>004962215636223</phone>
    <email>arianeb.mehrabi@med.uni-heidelberg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Surgery clinic</name>
      <address>
        <city>Heidelberg</city>
        <zip>69493</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arianeb Mehrabi</last_name>
      <phone>004962215636223</phone>
      <email>arianeb.mehrabi@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Professor Dr. med. Arianeb Mehrabi</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arianeb Mehrabi</last_name>
      <phone>004962215636223</phone>
      <email>arianeb.mehrabi@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 14, 2021</study_first_submitted>
  <study_first_submitted_qc>April 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>Dr. A. Mehrabi</investigator_full_name>
    <investigator_title>Professsor, Head of the Division of Liver Surgery and Visceral Transplantation</investigator_title>
  </responsible_party>
  <keyword>Pancreatectomy</keyword>
  <keyword>Gastric venous outflow reconstruction</keyword>
  <keyword>Gastric venous congestion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Upon reasonable request, the data generated by the current research that supports our future article, would be made available as soon as possible, wherever legally and ethically possible.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

